Last medical review: April 2026 · Reading time: 6 min
Important notice: This content is for educational purposes and does not replace the opinion of your treating physician. Results may vary. The medical assessment defines eligibility, protocol, and costs. Always consult with the medical team before starting any treatment.
Maintaining an active and competitive lifestyle after the age of forty is an achievable and healthy goal. However, the body undergoes natural physiological changes; tissue regeneration slows down, and accumulated wear and tear can turn a temporary discomfort into a chronic condition. For many sports enthusiasts, the fear of premature retirement from their favorite discipline becomes real when conventional treatments are limited to masking the pain without addressing the structural root of the problem.
The challenge of muscle and joint recovery in athletic maturity
Over time, fundamental structures such as tendons, ligaments, and cartilage lose some of their elasticity and intrinsic self-repair capacity. Conditions such as plantar fasciitis, tendinopathies, muscle-tendon tears, and rotator cuff injuries become more frequent and difficult to overcome. In this scenario, the traditional approach usually focuses on prolonged rest, physical therapy, or the use of anti-inflammatories which, although useful for managing acute symptoms, can weaken tissue metabolism in the long run.
This is where evidence-based regenerative medicine offers a new paradigm. Far from seeking temporary solutions, the goal is to provide the body with the biological tools necessary to foster an environment conducive to structural recovery.
Stem Cells and Exosomes: Science applied to physical performance
Umbilical cord-derived mesenchymal stem cells (UC-MSC) represent one of the most promising advances in the field of tissue regeneration. These cells, along with extracellular vesicles or exosomes, act as powerful biological modulators at the site of injury.
Their mechanism of action is based on rigorously studied pathways:
- Differentiation and structural support: Under the appropriate stimuli of the injured microenvironment, they have the potential to favor cell lineages such as tenocytes, chondrocytes, and ligamentocytes, which are fundamental for repairing damaged connective tissue.
- Powerful paracrine activity: They release bioactive molecules that promote the formation of new blood vessels (angiogenesis), which is vital for delivering oxygen and nutrients to areas with poor blood supply such as tendons and menisci.
- Immunomodulation: They control and regulate the chronic inflammatory cascade, transforming a hostile and degenerative environment into one favorable for repair.
Intralesional application guided by specialists has shown remarkable benefits in the management of complex musculoskeletal conditions, significantly improving patients' functional performance and contributing to the overall health of the joints (we invite you to read this related publication on our portal to learn more about joint care).
The importance of safety and international standards
When it comes to advanced interventions, the quality and purity of biological components are non-negotiable. At Regencord, we understand that our patients' trust is built on scientific rigor and regulatory compliance. Our laboratory processes are developed under strict compliance with international standards.
We operate aligned with the ISO 9001 standard for quality management, the ISO 13022 standard focused on risk management for cellular products, and ISO 14644, which guarantees the air cleanliness classification in our cleanrooms. Furthermore, each delivered cellular concentrate is accompanied by a certificate validating its identity through flow cytometry, confirming optimal cell viability and absolute sterility against infectious agents.
This quality framework ensures that athletes seeking to overcome sports injuries access therapies with an exceptional safety profile.
Frequently Asked Questions
Is any athlete with joint pain a candidate for cell therapy?
Not all patients or all injuries are the same. Eligibility is strictly defined through an individualized medical assessment, where a team of specialists evaluates the medical history, imaging studies, and the level of structural damage. This clinical step is essential to determine if the patient will benefit from the treatment.
Is this considered alternative medicine?
Not at all. We distance ourselves from unregulated concepts; what we offer is evidence-based regenerative medicine. Our protocols are based on global clinical research and rigorous quality control under ISO certifications (such as ISO 9001 and ISO 14644), led by medical doctors and scientists affiliated with international cell therapy societies.
Are results guaranteed to return to sports quickly?
Human biology is complex, and results vary from individual to individual. No ethical procedure can guarantee absolute results. Our approach prioritizes safety, the control of chronic inflammation, and regenerative support to improve your quality of life and functional performance, accompanying the process hand-in-hand with our specialists.
References
- Clinical application of umbilical cord-derived mesenchymal stem cells (UC-MSC) in the repair of musculoskeletal tissues.
- Safety and efficacy protocols in intralesional administration for the treatment of musculoskeletal injuries and tendinopathies.
- Quality standards and regulatory certifications for biobanks and processing of viable human cells.
Is a recurring injury slowing down your lifestyle and sports goals?
Don't let joint or muscle wear define your future in sports. Discover if regenerative medicine can provide the structural and anti-inflammatory support your body needs. Our team of specialists is ready to guide you with total scientific rigor and transparency.
Book your medical assessment at no cost
